Expression of antimicrobial peptides in diabetic foot ulcer

Journal of Dermatological Science

Volumn 65, Issue 1, 2012, Pages 19-26

  Rivas Santiago, Bruno ^a   Trujillo, Valentín ^a   Montoya, Alejandra ^a   Gonzalez Curiel, Irma ^a   Castañeda Delgado, Julio ^a   Cardenas, Albertina ^a   Rincon, Kublai ^a   Hernandez, Maria L ^a   Hernández Pando, Rogelio ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b National Institute for Medica Sciences and Nutrition Salvador Zubiran   (Mexico)

Author keywords

Antimicrobial peptides; Cathelicidin; Defensin; Diabetic foot ulcer

Indexed keywords

ANTIBIOTIC AGENT; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DEFENSIN 1; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAMP GENE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; DEFA1 GENE; DEFB1 GENE; DEFB103A GENE; DEFB104 GENE; DEFB4 GENE; DIABETIC FOOT; DISEASE CLASSIFICATION; EPIDERMIS CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; ULCEROGENESIS; WOUND HEALING IMPAIRMENT;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; BIOPSY; CASE-CONTROL STUDIES; CELLS, CULTURED; DIABETES COMPLICATIONS; DIABETIC FOOT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SKIN; STAPHYLOCOCCUS AUREUS; ULCER; WOUND HEALING;

EID: 84855205528     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.09.013     Document Type: Article

References (31)

1. Harder J., Schroder J.M. Antimicrobial peptides in human skin. Chem Immunol Allergy 2005, 86:22-41.
2. Glaser R., Harder J., Lange H., Bartels J., Christophers E., Schroder J.M. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005, 6:57-64.
3. Steinstraesser L., Koehler T., Jacobsen F., Daigeler A., Goertz O., Langer S., et al. Host defense peptides in wound healing. Mol Med 2008, 14:528-537.
4. Harder J., Meyer-Hoffert U., Wehkamp K., Schwichtenberg L., Schroder J.M. Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 2004, 123:522-529.
5. Fulton C., Anderson G.M., Zasloff M., Bull R., Quinn A.G. Expression of natural peptide antibiotics in human skin. Lancet 1997, 350:1750-1751.
6. Harder J., Bartels J., Christophers E., Schroder J.M. Isolation and characterization of human beta-defensin-3 a novel human inducible peptide antibiotic. J Biol Chem 2001, 276:5707-5713.
7. Oono T., Shirafuji Y., Huh W.K., Akiyama H., Iwatsuki K. Effects of human neutrophil peptide-1 on the expression of interstitial collagenase and type I collagen in human dermal fibroblasts. Arch Dermatol Res 2002, 294:185-189.
8. Niyonsaba F., Ushio H., Nakano N., Ng W., Sayama K., Hashimoto K., et al. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 2007, 127:594-604.
9. Khanolkar M.P., Bain S.C., Stephens J.W. The diabetic foot. QJM 2008, 101:685-695.
10. Bader M.S. Diabetic foot infection. Am Fam Physician 2008, 78:71-79.
11. Jeffcoate W.J., Game F., Cavanagh P.R. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute charcot foot) in diabetes. Lancet 2005, 366:2058-2061.
12. Jeffcoate W.J. Theories concerning the pathogenesis of the acute charcot foot suggest future therapy. Curr Diab Rep 2005, 5:430-435.
13. Heilborn J.D., Nilsson M.F., Kratz G., Weber G., Sorensen O., Borregaard N., et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 2003, 120:379-389.
14. Dressel S., Harder J., Cordes J., Wittersheim M., Meyer-Hoffert U., Sunderkotter C., et al. Differential expression of antimicrobial peptides in margins of chronic wounds. Exp Dermatol 2010, 19:628-632.
15. Butmarc J., Yufit T., Carson P., Falanga V. Human beta-defensin-2 expression is increased in chronic wounds. Wound Repair Regen 2004, 12:439-443.
16. Galkowska H., Olszewski W.L., Wojewodzka U. Keratinocyte and dermal vascular endothelial cell capacities remain unimpaired in the margin of chronic venous ulcer. Arch Dermatol Res 2005, 296:286-295.
17. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
18. Stephens K., Zlotogorski A., Smith L., Ehrlich P., Wijsman E., Livingston R.J., et al. Epidermolysis bullosa simplex: a keratin 5 mutation is a fully dominant allele in epidermal cytoskeleton function. Am J Hum Genet 1995, 56:577-585.
19. Ochoa O., Torres F.M., Shireman P.K. Chemokines and diabetic wound healing. Vascular 2007, 15:350-355.
20. Zheng Y., Niyonsaba F., Ushio H., Ikeda S., Nagaoka I., Okumura K., et al. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology 2008, 124:357-367.
21. Mowat A., Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971, 284:621-627.
22. Mowat A.G., Baum J. Polymorphonuclear leucocyte chemotaxis in patients with bacterial infections. Br Med J 1971, 3:617-619.
23. Lundqvist K., Sorensen O.E., Schmidtchen A. Increased levels of human neutrophil alpha-defensins in chronic venous leg ulcers. J Dermatol Sci 2008, 51:131-134.
24. Yamasaki K., Gallo R.L. Antimicrobial peptides in human skin disease. Eur J Dermatol 2008, 18:11-21.
25. Rivas-Santiago B., Serrano C.J., Enciso-Moreno J.A. Susceptibility to infectious diseases based on antimicrobial peptide production. Infect Immun 2009, 77:4690-4695.
26. Kesting M.R., Stoeckelhuber M., Holzle F., Mucke T., Neumann K., Woermann K., et al. Expression of antimicrobial peptides in cutaneous infections after skin surgery. Br J Dermatol 2010, 163:121-127.
27. Galkowska Hanna O.W. Wojewodzka Urzula: expression of natural antimicrobial peptides β-defensin-2 and langherhans cell accumulation in epidermis from human non-healing leg ulcer. Folia Histochem Cytobiol 2005, 43:4.
28. Gonzalez-Curiel I., Castaneda-Delgado J., Lopez-Lopez N., Araujo Z., Hernandez-Pando R., Gandara-Jasso B., et al. Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus. Hum Immunol 2011, 72:656-662.
29. Carretero M., Escamez M.J., Garcia M., Duarte B., Holguin A., Retamosa L., et al. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J Invest Dermatol 2008, 128:223-236.
30. Yin J., Yu F.S. LL-37 via EGFR transactivation to promote high glucose-attenuated epithelial wound healing in organ-cultured corneas. Invest Ophthalmol Vis Sci 2010, 51:1891-1897.
31. Tokumaru S., Sayama K., Shirakata Y., Komatsuzawa H., Ouhara K., Hanakawa Y., et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 2005, 175:4662-4668.